Skip to main content
Erschienen in:

01.11.2019 | Nephrology - Original Paper

The association of the decline in glomerular filtration rate with aggressive endometrial cancers

verfasst von: Vedran Premuzic, Egon Kruezi, Matea Berovic, Lana Leko, Lucija Susnjar, Ingrid Marton, Drazan Butorac, Dubravko Habek

Erschienen in: International Urology and Nephrology | Ausgabe 1/2020

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Most site-specific cancer incidence is increased with the decrease of glomerular filtration rate (GFR). We analyzed endometrial cancers depending on different type, staging, and histology grades. We hypothesized that patients with lower GFR levels have an increased risk for higher staging and histology grades of endometrial cancers.

Methods

Patients were divided into two subgroups regarding GFR; the first group with GFR < 60 ml/min and the second group with GFR > 60 ml/min and regarding different histology grades and cancer stages. Cancers were also divided by stages (1–4). Patients were followed up during 1 year through regular controls in the outpatient clinic and during that time cancer recurrence was recorded.

Results

GFR was the strongest predictor for higher cancer histology grade and higher cancer staging. Patients with reduced GFR had OR for higher histology grade and higher staging of 1.06 and 1.06. Traditional risk factors for endometrial cancer development were not associated with higher histology grade or higher cancer staging.

Conclusion

Higher staging and histology grades in patients with endometrial cancers are associated with reduced GFR. Patients with mild-to-moderate CKD had significantly higher number of cancers with higher histology grades and higher stages than patients with mild or normal GFR category. Decline in GFR was independently associated with more aggressive cancers without other well-known risk factors for endometrial cancer development like age, menopause, diabetes, and obesity.
Literatur
1.
Zurück zum Zitat Weng PH, Hung KY, Huang H et al (2011) Cancer-specific mortality in chronic kidney disease: longitudinal follow-up of a large cohort. Clin J Am Soc Nephrol 6(5):1121–1128CrossRef Weng PH, Hung KY, Huang H et al (2011) Cancer-specific mortality in chronic kidney disease: longitudinal follow-up of a large cohort. Clin J Am Soc Nephrol 6(5):1121–1128CrossRef
2.
Zurück zum Zitat Maisonneuve P, Agodoa L, Gellert R et al (1999) Cancer in patients on dialysis for end-stage renal disease: an International Collaborative Study. Lancet 354:93–99CrossRef Maisonneuve P, Agodoa L, Gellert R et al (1999) Cancer in patients on dialysis for end-stage renal disease: an International Collaborative Study. Lancet 354:93–99CrossRef
3.
Zurück zum Zitat Cengiz K (2002) Increased incidence of neoplasia in chronic renal failure (20-year experience). Int Urol Nephrol 33:121–126CrossRef Cengiz K (2002) Increased incidence of neoplasia in chronic renal failure (20-year experience). Int Urol Nephrol 33:121–126CrossRef
4.
Zurück zum Zitat Dalrymple LS, Katz R, Kestenbaum B et al (2011) Chronic kidney disease and the risk of end-stage renal disease versus death. J Gen Intern Med 26(4):379–385CrossRef Dalrymple LS, Katz R, Kestenbaum B et al (2011) Chronic kidney disease and the risk of end-stage renal disease versus death. J Gen Intern Med 26(4):379–385CrossRef
5.
Zurück zum Zitat Iff S, Craig JC, Turner R et al (2014) Reduced estimated GFR and cancer mortality. Am J Kidney Dis 63(1):23–30CrossRef Iff S, Craig JC, Turner R et al (2014) Reduced estimated GFR and cancer mortality. Am J Kidney Dis 63(1):23–30CrossRef
6.
Zurück zum Zitat Fried LF, Katz R, Sarnak MJ et al (2005) Kidney function as a predictor of noncardiovascular mortality. J Am Soc Nephrol 16(12):3728–3735CrossRef Fried LF, Katz R, Sarnak MJ et al (2005) Kidney function as a predictor of noncardiovascular mortality. J Am Soc Nephrol 16(12):3728–3735CrossRef
7.
Zurück zum Zitat Yang Y, Li H, Zhou Q et al (2016) Renal function and all-cause mortality risk among cancer patients. Medicine (Baltimore) 95(20):e3728CrossRef Yang Y, Li H, Zhou Q et al (2016) Renal function and all-cause mortality risk among cancer patients. Medicine (Baltimore) 95(20):e3728CrossRef
8.
Zurück zum Zitat Kato S, Chmielewski M, Honda H et al (2008) Aspects of immune dysfunction in end-stage renal disease. Clin J Am Soc Nephrol 3(5):1526–1533CrossRef Kato S, Chmielewski M, Honda H et al (2008) Aspects of immune dysfunction in end-stage renal disease. Clin J Am Soc Nephrol 3(5):1526–1533CrossRef
9.
Zurück zum Zitat Reuter S, Gupta SC, Chaturvedi MM et al (2010) Oxidative stress, inflammation, and cancer. How are they linked? Free Radic Biol Med 49(11):1603–1616CrossRef Reuter S, Gupta SC, Chaturvedi MM et al (2010) Oxidative stress, inflammation, and cancer. How are they linked? Free Radic Biol Med 49(11):1603–1616CrossRef
10.
Zurück zum Zitat Wilson WEC, Kirkpatrick CH, Talmage DW (1965) Suppression of immunologic responsiveness in uraemia. Ann Intern Med 62:1CrossRef Wilson WEC, Kirkpatrick CH, Talmage DW (1965) Suppression of immunologic responsiveness in uraemia. Ann Intern Med 62:1CrossRef
11.
Zurück zum Zitat Vajdic CM, McDonald SP, McCredie MR et al (2006) Cancer incidence before and after kidney transplantation. JAMA 296:2823–2831CrossRef Vajdic CM, McDonald SP, McCredie MR et al (2006) Cancer incidence before and after kidney transplantation. JAMA 296:2823–2831CrossRef
12.
Zurück zum Zitat Shebl FM, Warren JL, Eggers PW et al (2012) Cancer risk among elderly persons with end-stage renal disease: a population-based case-control study. BMC Nephrol 13:65CrossRef Shebl FM, Warren JL, Eggers PW et al (2012) Cancer risk among elderly persons with end-stage renal disease: a population-based case-control study. BMC Nephrol 13:65CrossRef
13.
Zurück zum Zitat Wong G, Staplin N, Emberson J et al (2016) Chronic kidney disease and the risk of cancer: an individual patient data meta-analysis of 32,057 participants from six prospective studies. BMC Cancer 16:488CrossRef Wong G, Staplin N, Emberson J et al (2016) Chronic kidney disease and the risk of cancer: an individual patient data meta-analysis of 32,057 participants from six prospective studies. BMC Cancer 16:488CrossRef
14.
Zurück zum Zitat Chang WF, Horng HC, Yeh CC et al (2018) Risk of female genital tract related cancers (gynecological cancers) or breast cancer in women with and without chronic kidney disease. A population-based cohort study in Taiwan. Medicine (Baltimore) 97(12):e0157CrossRef Chang WF, Horng HC, Yeh CC et al (2018) Risk of female genital tract related cancers (gynecological cancers) or breast cancer in women with and without chronic kidney disease. A population-based cohort study in Taiwan. Medicine (Baltimore) 97(12):e0157CrossRef
15.
Zurück zum Zitat Chavan DM, Huang Z, Song K et al (2017) Incidence of venous thromboembolism following the neoadjuvant chemotherapy regimen for epithelial type of ovarian cancer. Medicine (Baltimore) 96:e7935CrossRef Chavan DM, Huang Z, Song K et al (2017) Incidence of venous thromboembolism following the neoadjuvant chemotherapy regimen for epithelial type of ovarian cancer. Medicine (Baltimore) 96:e7935CrossRef
16.
Zurück zum Zitat Clarke-Pearson DL (2009) Clinical practice. Screening for ovarian cancer. N Engl J Med 361(2):170–177CrossRef Clarke-Pearson DL (2009) Clinical practice. Screening for ovarian cancer. N Engl J Med 361(2):170–177CrossRef
17.
Zurück zum Zitat Rule AD (2010) The CKD-EPI equation for estimating GFR from serum creatinine: real improvement or more of the same? Clin J Am Soc Nephrol 5:6951–6953CrossRef Rule AD (2010) The CKD-EPI equation for estimating GFR from serum creatinine: real improvement or more of the same? Clin J Am Soc Nephrol 5:6951–6953CrossRef
18.
Zurück zum Zitat Creasman W (2009) Revised FIGO staging for carcinoma oft he endometrium. Int J Gynaecol Obstet 105(2):109CrossRef Creasman W (2009) Revised FIGO staging for carcinoma oft he endometrium. Int J Gynaecol Obstet 105(2):109CrossRef
19.
Zurück zum Zitat Kurman RJ, Carangin ML, Herrington CY et al (2014) WHO Classification of the tumors of the female reproductive organs. World Health Organisation, pp 126, 150 Kurman RJ, Carangin ML, Herrington CY et al (2014) WHO Classification of the tumors of the female reproductive organs. World Health Organisation, pp 126, 150
20.
Zurück zum Zitat Salani R, Backes FJ, Fung MF et al (2011) Posttreatment surveillance and diagnosis of recurrence in women with gynecologic malignancies: Society of Gynecologic Oncologist recommendations. Am J Obstet Gynecol 204(6):466CrossRef Salani R, Backes FJ, Fung MF et al (2011) Posttreatment surveillance and diagnosis of recurrence in women with gynecologic malignancies: Society of Gynecologic Oncologist recommendations. Am J Obstet Gynecol 204(6):466CrossRef
21.
Zurück zum Zitat Croatian Institute of Public Health (2016) The Croatian National Cancer Registry. Cancer incidence in Croatia for 2014. Bulletin No. 39 Croatian Institute of Public Health (2016) The Croatian National Cancer Registry. Cancer incidence in Croatia for 2014. Bulletin No. 39
22.
Zurück zum Zitat Donin NM, Suh LK, Barlow L et al (2012) Tumour diameter and decreased preoperative estimated glomerular filtration rate are independently correlated in patients with renal cell carcinoma. BJU Int 109(3):379–383CrossRef Donin NM, Suh LK, Barlow L et al (2012) Tumour diameter and decreased preoperative estimated glomerular filtration rate are independently correlated in patients with renal cell carcinoma. BJU Int 109(3):379–383CrossRef
23.
24.
Zurück zum Zitat Izzedine H, Perazella MA (2015) Onco-nephrology: an appraisal of the cancer and chronic kidney disease links. Nephrol Dial Transplant 30(12):1979–1988CrossRef Izzedine H, Perazella MA (2015) Onco-nephrology: an appraisal of the cancer and chronic kidney disease links. Nephrol Dial Transplant 30(12):1979–1988CrossRef
25.
Zurück zum Zitat Luo F, Wang YS, Su YH et al (2017) Prognostic implications of preoperative anemia in urothelial carcinoma: a meta-analysis. PLoS One 12(2):e0171701CrossRef Luo F, Wang YS, Su YH et al (2017) Prognostic implications of preoperative anemia in urothelial carcinoma: a meta-analysis. PLoS One 12(2):e0171701CrossRef
26.
Zurück zum Zitat Premuzic V, Gamulin M, Coric M et al (2017) The incidence of urinary tract cancers is related to preserved diuresis: a single-center report. Int Urol Nephrol 49(12):2257–2263CrossRef Premuzic V, Gamulin M, Coric M et al (2017) The incidence of urinary tract cancers is related to preserved diuresis: a single-center report. Int Urol Nephrol 49(12):2257–2263CrossRef
27.
Zurück zum Zitat Espersen T, Schmitz O, Hanse HE et al (1988) Ovulation in uremic women: the reproductive cycle in women on chronic hemodialysis. Int J Fertil 33(2):103–106PubMed Espersen T, Schmitz O, Hanse HE et al (1988) Ovulation in uremic women: the reproductive cycle in women on chronic hemodialysis. Int J Fertil 33(2):103–106PubMed
28.
Zurück zum Zitat Zingraff J, Jungers P, Pelissier C et al (1982) Pituitary and ovarian dysfunctions in women on hemodialysis. Nephron 30(2):149–153CrossRef Zingraff J, Jungers P, Pelissier C et al (1982) Pituitary and ovarian dysfunctions in women on hemodialysis. Nephron 30(2):149–153CrossRef
29.
Zurück zum Zitat Ergeneli MH, Duran EH, Zeyneloglu HB et al (1999) Endometrial response to unopposed estrogens remains unaltered in patients with chronic renal failure receiving hemodialysis. Gynecol Obstet Invest 47(1):26–28CrossRef Ergeneli MH, Duran EH, Zeyneloglu HB et al (1999) Endometrial response to unopposed estrogens remains unaltered in patients with chronic renal failure receiving hemodialysis. Gynecol Obstet Invest 47(1):26–28CrossRef
30.
Zurück zum Zitat Fucic A, Gamulin M, Ferencic Z et al (2012) Environmental exposure to xenoestrogens and oestrogen related cancers: reproductive system, breast, lung, kidney pancreas, and brain. Environ Health 11(suppl 1):S8CrossRef Fucic A, Gamulin M, Ferencic Z et al (2012) Environmental exposure to xenoestrogens and oestrogen related cancers: reproductive system, breast, lung, kidney pancreas, and brain. Environ Health 11(suppl 1):S8CrossRef
Metadaten
Titel
The association of the decline in glomerular filtration rate with aggressive endometrial cancers
verfasst von
Vedran Premuzic
Egon Kruezi
Matea Berovic
Lana Leko
Lucija Susnjar
Ingrid Marton
Drazan Butorac
Dubravko Habek
Publikationsdatum
01.11.2019
Verlag
Springer Netherlands
Erschienen in
International Urology and Nephrology / Ausgabe 1/2020
Print ISSN: 0301-1623
Elektronische ISSN: 1573-2584
DOI
https://doi.org/10.1007/s11255-019-02324-w

Kompaktes Leitlinien-Wissen Innere Medizin (Link öffnet in neuem Fenster)

Mit medbee Pocketcards schnell und sicher entscheiden.
Leitlinien-Wissen kostenlos und immer griffbereit auf ihrem Desktop, Handy oder Tablet.

Neu im Fachgebiet Innere Medizin

Krebsscreeningprogramme erreichen Menschen mit kognitiver Beeinträchtigung schlechter

Daten aus den Niederlanden zeigen, dass Krebsfrüherkennungsmaßnahmen für Menschen mit Störungen der Intelligenzentwicklung häufig nicht zugänglich sind. Wie kann diese Lücke geschlossen werden?

Perkutane Ablation – ungenutztes Potenzial für die Schmerztherapie?

Geht es nach US-Versicherungsdaten, ist die perkutane Ablation eine vorteilhafte, aber zu selten genutzte Option in der Schmerzlinderung von Personen mit bestimmten Tumoren. Wichtige Fragen bleiben allerdings unbeantwortet.

Reduzieren Kälte und Kompression die CIPN-Gefahr in den Händen?

Ergebnisse der deutschen POLAR-Studie sprechen dafür, dass kühlende oder komprimierende Handschuhe das Risiko für eine Taxan-induzierte periphere Neuropathie senken können. Ein paar Fragen bleiben aber offen.

Spricht eine hohe eGFR-Variabilität für eine ungünstige Prognose?

Variiert die geschätzte glomeruläre Filtrationsleistung von Messung zu Messung deutlich, ist das bei Menschen mit chronischer Niereninsuffizienz ein ungünstiges Zeichen, nicht nur mit Blick auf die Niere. Dafür spricht zumindest eine Auswertung der CRIC-Studie.

EKG Essentials: EKG befunden mit System (Link öffnet in neuem Fenster)

In diesem CME-Kurs können Sie Ihr Wissen zur EKG-Befundung anhand von zwölf Video-Tutorials auffrischen und 10 CME-Punkte sammeln.
Praxisnah, relevant und mit vielen Tipps & Tricks vom Profi.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.